Skip to main content
Research article - Peer-reviewed, 2021

COMP (Cartilage Oligomeric Matrix Protein) Neoepitope A Novel Biomarker to Identify Symptomatic Carotid Stenosis

Sandstedt, Joakim; Vargmar, Karin; Bjorkman, Kristina; Ruetschi, Ulla; Bergstrom, Goran; Hulten, Lillemor Mattsson; Skioldebrand, Eva

Abstract

Objective:COMP (cartilage oligomeric matrix protein) is abundantly expressed in the cardiovascular system, cartilage, and atherosclerotic plaques. We investigated if the total COMP (COMPtotal) and COMP neoepitope (COMPneo) with other cardiovascular markers and clinical parameters could identify symptomatic carotid stenosis.Approach and Results:Blood samples were collected from patients with symptomatic carotid stenosis (stenosis, n=50), patients with stroke without carotid stenosis but small plaques (plaque, n=50), and control subjects (n=50). COMPtotal and COMPneo were measured using an ELISA. Ninety-two cardiovascular disease markers were measured by the Olink CVD kit. The presence of native COMP and COMPneo was determined by immunohistochemistry. The concentration of COMPneo was higher and COMPtotal was lower in the stenosis group. When the concentration was compared between the stenosis and control groups, IL-1ra (interleukin-1 receptor antagonist protein), IL6 (interleukin-6), REN (Renin), MMP1 (matrix metalloproteinase-1), TRAIL-R2 (tumor necrosis factor-related apoptosis-inducing ligand receptor 2), ITGB1BP2 (integrin beta 1 binding protein 2), and COMPneo were predictive of stenosis. Conversely, KLK6 (kallikrein-6), COMPtotal, NEMO (nuclear factor-kappa-B essential modulator), SRC (Proto-oncogene tyrosine-protein kinase Src), SIRT2 (SIR2-like protein), CD40 (cluster of differentiation 40), TF (tissue factor), MP (myoglobin), and RAGE (receptor for advanced glycation end-products) were predictive of the control group. Model reproducibility was good with the receiver operating characteristic plot area under the curve being 0.86. When comparing the plaque group and stenosis group, COMPneo, GAL (galanin), and PTX3 (pentraxin-related protein PTX3) were predictive of stenosis. Model reproducibility was excellent (receiver operating characteristic plot area under the curve 0.92). COMPneo was detected in smooth muscle-, endothelial-, and foam-cells in carotid stenosis.Conclusions:Degradation of COMP may be associated with atherosclerosis progression and generation of a specific COMP fragment-COMPneo. This may represent a novel biomarker that together with COMPtotal and other risk-markers could be used to identify symptomatic carotid stenosis.

Keywords

atherosclerosis; biomarker; carotid stenosis; extracellular matrix proteins; plasma; stroke

Published in

Arteriosclerosis, thrombosis, and vascular biology
2021, volume: 41, number: 3, pages: 1218-1228
Publisher: LIPPINCOTT WILLIAMS AND WILKINS

Authors' information

Sandstedt, Joakim
Sahlgrenska University Hospital
Sandstedt, Joakim
University of Gothenburg
Bjorkman, Kristina
University of Gothenburg
Ruetschi, Ulla
University of Gothenburg
Ruetschi, Ulla
Sahlgrenska University Hospital
Bergstrom, Goran
University of Gothenburg
Hulten, Lillemor Mattsson
Sahlgrenska University Hospital
Hulten, Lillemor Mattsson
University of Gothenburg

Sustainable Development Goals

SDG3 Good health and wellbeing

UKÄ Subject classification

Cardiac and Cardiovascular Systems

Publication Identifiers

DOI: https://doi.org/10.1161/ATVBAHA.120.314720

URI (permanent link to this page)

https://res.slu.se/id/publ/112160